ChronoScale Holdings Corp
CHRN Nasdaq General Industrial Machinery & Equipment, Nec Financials FY2016βFY2026
What ChronoScale Holdings Corp does
No business description yet.
- Legal name
- ChronoScale Holdings Corp
- Fiscal year ends
- May 31, 2026
- Latest annual report
- 10-K Β· Aug 19, 2026
- Accession Β· CIK
- 0001628280-26-058018
0001549084
Revenue and margins
ChronoScale Holdings Corp had $17.9M of revenue in fiscal 2026.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$9.9M in fiscal 2026, β55.1% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
ChronoScale Holdings Corp returned β to shareholders in fiscal 2026. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably ChronoScale Holdings Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $12.9M | $40.4M | $20.5M | $8.6M | $9.7M |
| Debt incl. finance leases | $2.0M | $2.0M | β | β | $62.1M |
| Debt / equity | 0.4x | 0.1x | β | β | 0.0x |
| Interest coverage | β95.6x | β122.4x | β99.7x | β50.0x | β38.9x |
| Current ratio | 3.7x | 7.0x | 3.4x | 2.5x | 0.5x |
| Quick ratio | 3.3x | 6.6x | 2.8x | 1.9x | 0.5x |
| Total assets | $20.6M | $49.2M | $40.9M | $28.9M | $326M |
| Total liabilities | $16.2M | $11.9M | $15.5M | $16.3M | $144M |
| Shareholders' equity | $4.4M | $37.2M | $25.4M | $12.6M | $180M |
| Net debt (β = net cash) | β$10.9M | β$38.4M | β | β | $52.5M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 4 / 9 | 3 / 9 | 5 / 9 | 4 / 9 | 4 / 9 | 2 / 8 | 3 / 8 | β / 3 |
| Accruals ratio | β4.1% | 5.4% | 6.7% | β17.3% | 18.4% | β33.3% | 4.0% | β0.9% | β9.0% | β0.5% |
| Altman Z'' | β9.98 | β18.68 | β12.16 | β39.88 | β28.61 | β31.28 | β7.01 | β15.17 | β26.92 | β1.76 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $8.7M | $14.2M | $7.4M | $11.3M | $13.9M | $8.9M | $11.2M | $12.9M | $18.3M | $17.9M |
| Gross profit | $1.2M | $2.9M | $2.1M | $4.3M | $6.8M | $5.1M | $6.7M | $6.2M | $9.1M | $9.5M |
| Research and development | $6.5M | $8.9M | $9.5M | $5.8M | $4.6M | $2.5M | $2.5M | $3.6M | $5.0M | $3.9M |
| Operating income | β$21.6M | β$27.6M | β$31.6M | β$27.0M | β$16.6M | β$13.3M | β$13.8M | β$15.6M | β$15.1M | β$10.5M |
| Interest expense | $0.0M | $0.0M | $0.6M | $0.6M | $0.4M | $0.1M | $0.1M | $0.2M | $0.3M | $0.3M |
| Pretax income | β$19.6M | β$23.5M | β$29.1M | β$27.0M | β$12.1M | β$15.8M | β$9.8M | β$15.1M | β$15.2M | β$11.3M |
| Net income | β$19.6M | β$23.5M | β$29.1M | β$27.0M | β$12.1M | β$15.8M | β$9.8M | β$15.1M | β$15.2M | β$11.3M |
| Net income to common | β$24.2M | β$33.8M | β$29.1M | β$27.0M | β$12.1M | β$15.8M | β$9.8M | β$15.1M | β$15.2M | β$11.3M |
| Diluted EPS | β$1.83 | β$2.05 | β$0.82 | β$0.44 | β$2.53 | β$2.21 | β$0.88 | β$1.16 | β$1.10 | β$8.43 |
| Diluted shares | 0.01B | 0.02B | 0.04B | 0.06B | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | β$18.3M | β$25.0M | β$31.2M | β$22.2M | β$15.8M | β$8.8M | β$11.2M | β$14.7M | β$12.1M | β$9.8M |
| Capital expenditure | $1.5M | $1.1M | $0.5M | $0.1M | $0.1M | $0.0M | $0.1M | $0.2M | $0.2M | $0.0M |
| Free cash flow | β$19.8M | β$26.1M | β$31.7M | β$22.3M | β$15.8M | β$8.8M | β$11.2M | β$14.9M | β$12.2M | β$9.9M |
| Depreciation and amortization | $0.9M | $1.9M | $1.2M | $1.0M | $0.7M | $0.6M | $1.0M | $0.9M | $1.7M | $1.6M |
| Stock-based compensation | $1.7M | $3.1M | $2.4M | $2.9M | $2.3M | $2.4M | $2.3M | $2.5M | $1.9M | $1.4M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $19.6M | $16.8M | $27.8M | $7.7M | $10.9M | $12.9M | $40.4M | $20.5M | $8.6M | $9.7M |
| Total debt | $0.2M | $6.8M | $7.0M | $5.0M | $2.7M | $2.0M | $2.0M | β | β | $3.8M |
| Finance lease liabilities | β | β | β | β | β | β | β | β | β | $58.3M |
| Current assets | $25.2M | $20.7M | $34.9M | $15.0M | $18.8M | $18.4M | $47.8M | $31.0M | $20.2M | $44.2M |
| Current liabilities | $8.6M | $6.3M | $9.2M | $10.1M | $7.8M | $5.0M | $6.9M | $9.2M | $8.1M | $86.9M |
| Inventory | $1.1M | $1.6M | $3.0M | $3.4M | $2.5M | $2.0M | $2.2M | $5.2M | $5.1M | β |
| Property and equipment, net | $2.6M | $2.4M | $2.2M | $2.4M | $1.7M | $1.2M | $1.0M | $2.7M | $2.0M | $32.1M |
| Goodwill | $0.2M | $0.2M | $0.2M | $0.2M | $0.2M | $0.0M | $0.0M | $0.4M | $0.4M | $54.5M |
| Intangible assets | β | β | β | β | β | β | $0.0M | $5.2M | $4.9M | β |
| Total assets | $32.2M | $24.4M | $38.0M | $17.7M | $21.9M | $20.6M | $49.2M | $40.9M | $28.9M | $326M |
| Total liabilities | $23.4M | $17.9M | $16.6M | $14.9M | $15.1M | $16.2M | $11.9M | $15.5M | $16.3M | $144M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β |
| Shareholders' equity | $8.8M | $6.5M | $21.4M | $2.7M | $6.8M | $4.4M | $37.2M | $25.4M | $12.6M | $180M |
| Margins | ||||||||||
| Gross margin | 13.6% | 20.7% | 28.1% | 38.0% | 48.6% | 57.1% | 60.0% | 48.1% | 49.7% | 53.1% |
| Operating margin | β248.9% | β194.0% | β429.9% | β238.5% | β119.6% | β149.6% | β123.0% | β120.5% | β82.7% | β58.4% |
| EBITDA margin | β238.2% | β180.9% | β413.6% | β229.6% | β114.6% | β142.7% | β113.9% | β113.6% | β73.4% | β49.4% |
| Net margin | β226.2% | β165.0% | β396.1% | β238.2% | β87.2% | β178.2% | β86.8% | β116.8% | β83.1% | β63.2% |
| FCF margin | β228.2% | β183.5% | β430.9% | β196.8% | β113.8% | β98.6% | β99.7% | β115.3% | β66.8% | β55.1% |
| Returns | ||||||||||
| Return on capital | β | β | β4,565.5% | β39,543.9% | β | β | β | β | β | β4.7% |
| Return on capital employed | β91.4% | β152.4% | β109.7% | β356.8% | β118.1% | β85.1% | β32.7% | β49.1% | β72.7% | β4.4% |
| Return on equity | β222.4% | β306.0% | β208.6% | β223.8% | β254.7% | β281.8% | β46.9% | β48.1% | β79.9% | β6.3% |
| Return on assets | β60.8% | β82.9% | β93.3% | β97.0% | β61.3% | β74.4% | β28.0% | β33.5% | β43.5% | β3.5% |
| Return on tangible equity | β281.3% | β533.2% | β137.4% | β1,063.1% | β183.6% | β356.9% | β26.2% | β76.2% | β208.7% | β9.0% |
| Growth | ||||||||||
| Revenue growth | β | 64.2% | β48.3% | 54.1% | 22.8% | β36.2% | 26.6% | 14.8% | 41.6% | β |
| Share count change | β | 27.5% | 91.2% | 71.9% | β92.2% | 49.4% | 71.3% | 5.6% | 7.0% | β |
| Financial health | ||||||||||
| Debt / equity | 0.0x | 1.0x | 0.3x | 1.8x | 0.4x | 0.4x | 0.1x | β | β | 0.0x |
| Interest coverage | β1,658.5x | β1,724.1x | β48.8x | β45.1x | β43.3x | β95.6x | β122.4x | β99.7x | β50.0x | β38.9x |
| Current ratio | 2.9x | 3.3x | 3.8x | 1.5x | 2.4x | 3.7x | 7.0x | 3.4x | 2.5x | 0.5x |
| Quick ratio | 2.8x | 3.0x | 3.5x | 1.2x | 2.1x | 3.3x | 6.6x | 2.8x | 1.9x | 0.5x |
| Capital allocation | ||||||||||
| Capex / revenue | 17.2% | 7.7% | 6.2% | 1.2% | 0.4% | 0.0% | 0.5% | 1.5% | 0.9% | 0.2% |
| Stock comp / revenue | 20.0% | 21.9% | 32.8% | 25.3% | 16.2% | 27.1% | 20.7% | 19.7% | 10.2% | 7.7% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 4.0 | 3.0 | 5.0 | 4.0 | 4.0 | 2.0 | 3.0 | β |
| Altman Z'' | β10.0 | β18.7 | β12.2 | β39.9 | β28.6 | β31.3 | β7.0 | β15.2 | β26.9 | β1.8 |
| Accruals ratio | β4.1% | 5.4% | 6.7% | β17.3% | 18.4% | β33.3% | 4.0% | β0.9% | β9.0% | β0.5% |
Source: SEC EDGAR XBRL filings (CIK 0001549084). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.